专家简介
Professor Ivan HUNG (孔繁毅教授) is currently clinical professor and assistant dean,
Department of Medicine, LKS Faculty of Medicine, University of Hong Kong and
honorary consultant Queen Mary Hospital. He is a dual specialist in infectious disease
and gastroenterology & hepatology. He obtained his medical degree from the
University of Bristol, England in 1996. After working in the University of Cambridge
Medical School and Charing Cross Hospital, Imperial College Medical School,
London, he returned to Hong Kong in 1999 and joined the Department of Medicine,
Queen Mary Hospital. After obtaining his MRCP, he underwent subspecialty training
in infectious diseases, followed by gastroenterology and hepatology. He was a
Visiting Fellow at the Division of Geographical Medicine and Infectious Diseases,
Tufts-New England Medical Center, Boston, USA. He obtained his M.D. degree from
HKU in 2011 and was awarded the Sir Patrick Manson Gold Medal award for best
M.D. thesis. He is currently the Fellow of Royal Colleges of Physicians of London
and Edinburgh.
He has published more than 150 international peer reviewed original articles,
including research articles in the Lancet, the Lancet Infectious Diseases and the
Clinical Infectious Diseases. He and his team have pioneered the use of topical
imiquimod before intradermal influenza vaccination, which results in heterologous
protection against non-vaccine and antigenically drifted viruses. His team was also
the first to prove convalescent plasma reduced mortality in patients with severe
influenza infection in prospective clinical trials.
His research interest includes vaccine, antiviral treatment of influenza infection and
treatment of resistant Helicobacter pylori infection. He has an H-index of 37 and was
ranked world top 1% scientists in 2013. He is the Board & Founding Member of the
World Association for Infectious Diseases and Immunological Disorders. He is
Section Editor for the BMC Infectious Diseases and regular reviewer for many
infectious diseases and gastroenterology journals.
Department of Medicine, LKS Faculty of Medicine, University of Hong Kong and
honorary consultant Queen Mary Hospital. He is a dual specialist in infectious disease
and gastroenterology & hepatology. He obtained his medical degree from the
University of Bristol, England in 1996. After working in the University of Cambridge
Medical School and Charing Cross Hospital, Imperial College Medical School,
London, he returned to Hong Kong in 1999 and joined the Department of Medicine,
Queen Mary Hospital. After obtaining his MRCP, he underwent subspecialty training
in infectious diseases, followed by gastroenterology and hepatology. He was a
Visiting Fellow at the Division of Geographical Medicine and Infectious Diseases,
Tufts-New England Medical Center, Boston, USA. He obtained his M.D. degree from
HKU in 2011 and was awarded the Sir Patrick Manson Gold Medal award for best
M.D. thesis. He is currently the Fellow of Royal Colleges of Physicians of London
and Edinburgh.
He has published more than 150 international peer reviewed original articles,
including research articles in the Lancet, the Lancet Infectious Diseases and the
Clinical Infectious Diseases. He and his team have pioneered the use of topical
imiquimod before intradermal influenza vaccination, which results in heterologous
protection against non-vaccine and antigenically drifted viruses. His team was also
the first to prove convalescent plasma reduced mortality in patients with severe
influenza infection in prospective clinical trials.
His research interest includes vaccine, antiviral treatment of influenza infection and
treatment of resistant Helicobacter pylori infection. He has an H-index of 37 and was
ranked world top 1% scientists in 2013. He is the Board & Founding Member of the
World Association for Infectious Diseases and Immunological Disorders. He is
Section Editor for the BMC Infectious Diseases and regular reviewer for many
infectious diseases and gastroenterology journals.
美迪康会务通